Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2026-05-21 19:22:51 ET · period of report 2026-05-21 · accession 0001189014-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 19:22 | 2026-05-21 | NBIX | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +3,318 | 4,753 | +231% | $0 |
| D | 2026-05-21 19:22 | 2026-05-21 | NBIX | POON CHRISTINE A | Dir | M - OptEx | $0.00 | -3,318 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 3,318 | $0.00 | 4,753 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2026-05-21 | M | D | 3,318 | $0.00 | 0 | D | $0.00 · — to — | 3,318 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. (F2) This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested. (F2) This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested. |